This product is intended for research use only and is not approved for human consumption.
Several important safety considerations from the SmPC should be noted: If pancreatitis is suspected, Ozempic should be discontinued immediately and urgent medical assessment sought Patients should be counselled about gallbladder disease symptoms, as GLP-1 receptor agonists may increase the risk of gallstones [14] Those with pre-existing diabetic retinopathy should be monitored for potential worsening, particularly during rapid improvement in glucose control If a patient is taking warfarin or other coumarin derivatives, more frequent INR monitoring is recommended when starting Ozempic [1] Before initiating Ozempic in patients with known liver conditions, healthcare professionals should conduct a thorough assessment of liver disease severity, review concurrent medications for potential interactions, and establish baseline liver function tests

Mounjaro (Tirzepatide) Mounjaro is a newer medication, and unlike Wegovy and Ozempic, which contain semaglutide, Mounjaros active ingredient is tirzepatide
By slowing gastric emptying, semaglutide can help with losing weight and weight management
With the shortage resolved, the legal basis for 503B bulk compounding of semaglutide evaporated
Assisting in understanding risks Machine learning models are also trained to correlate thousands of metabolite profiles with long-term health outcomes, such as cardiovascular events, diabetic retinopathy, and other metabolic syndromes